Samsung Biologics launches drug screening services, Samsung Organoids
Samsung Organoids to provide data-driven analysis of candidate molecules Samsung Biologics expands service scope to include preclinical research INCHEON, South Korea, June 16, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading...